Cancer Drug Shows Promise for Alzheimer's
Neuroscientists at Case Western Reserve University's School of Medicine have made a dramatic breakthrough in their efforts to find a cure for Alzheimer's disease. The researchers' findings, published in the journal Science, show that use of a drug in mice appears to reverse the pathological, cognitive and memory deficits caused by the onset of Alzheimer's. The results point to the significant potential that the medication, bexarotene, has to help the roughly 5.4 million Americans suffering from the progressive brain disease. Read more
Professor Landreth and his research team appreciate the great interest inspired by their findings, but emphasize that clinical trials have not begun or been scheduled relating to this medication.
Learn more about Professor Landreth and his research
Microchip implant delivers drugs wirelessly
Professor James Anderson is part of a multi-institutional research team that recently completed first-in-human tests of a microchip implant that delivers medication according to directions delivered wirelessly from outside the body. The clinical trial involved eight women with osteoporosis. Surgeons installed the chips through a relatively minor procedure, and it then released daily doses of medications as directed by a computer programmer using a wireless device. The implants correctly performed the tasks, and the women reported no ill effects from the implants. The results carry significant promise for a broad range of regularly distributed medications, including for patients with cancer, multiple sclerosis and diabetes.
